corona latest news

Coronavirus News Highlights: Serum Institute gets DGCI’s nod to manufacture Sputnik V vaccine in India with certain conditions

Coronavirus Cases in India Highlights, Coronavirus Unlock Guidelines, Covid-19 Vaccine Latest Highlights: PM Modi hails Indian scientists for developing Covid vaccine.The Pune-based firm has collaborated with Gamaleya Research Institute of Epidemiology and Microbiology, Moscow in Russia for developing Sputnik V at its licensed Hadapsar facility.

 

Coronavirus Cases and Deaths in India Today, Covid-19 Vaccine Tracker:

The number of active Covid-19 cases in India has dipped further and experts believe that it is now in the zone where the existing health infrastructure can handle it. According to the Union Health Ministry, the daily positivity rate has now dropped to 6.21 per cent. The number of active cases has begun to fall in almost all the states and the biggest relief is that a dip is clearly visible in the daily count of deaths.

Meanwhile, over 22.37 lakh doses of vaccine have been administered in the country. The health ministry said that out of total people vaccine vaccinated so far, 99,24,634 are healthcare and 1,59,18,192 frontline workers who have taken the first dose.

However several states have started preparing to combat the possible third wave of COVID-19 pandemic. It must be noted that experts have warned that the third wave may affect people of different age groups along with children as anticipated.

Serum Institute gets DGCI’s nod to manufacture Sputnik V vaccine in India with certain conditions:

The DCGI has granted permission to the Serum Institute of India (SII) to manufacture the Sputnik COVID-19 vaccine in India for examination, test and analysis with certain conditions, official sources said. The Pune-based firm has collaborated with Gamaleya Research Institute of Epidemiology and Microbiology, Moscow in Russia for developing Sputnik V at its licensed Hadapsar facility. “The DCGI has granted permission to the Serum Institute to manufacture the Sputnik COVID-19 vaccine in India for examination, test and analysis at its licensed Hadapsar facility with certain conditions,” an official source said. The company had submitted an application to the DCGI in this regard on Thursday.

 

 

 

 

Get more stuff like this

Subscribe to our mailing list and get interesting stuff and updates to your email inbox.

Thank you for subscribing.

Something went wrong.

Leave a Comment

Your email address will not be published. Required fields are marked *

Join Our Facebook Group

Get more stuff like this
in your inbox

Subscribe to our mailing list and get interesting stuff and updates to your email inbox.

Thank you for subscribing.

Something went wrong.